Open an account

Pediatrix Medical Group

MD · NYSE

$28.08+$0.78 (+2.86%)TodayMarket closed ·
Prev close $27.30

About MD

Pediatrix Medical Group, Inc. engages in the provision of physician services. The company is headquartered in Sunrise, Florida and currently employs 2,295 full-time employees. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. The company offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. The company provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The firm provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.

Employees
2,295
Headquarters
Sunrise, Florida
Listed
Sep 20, 1995
Sector
Health Care
Industry
Health Care Providers & Services
Website
pediatrix.com

MD key statistics

Market cap
2.28B
Price-earnings ratio
13.06
Dividend yield
—
Average volume
672.43K
Volume
707.86K
Open price
$27.60
High today
$28.29
Low today
$27.30
52 Week high
$28.02
52 Week low
$16.47

Pediatrix Medical Group (MD) at a glance

Pediatrix Medical Group (MD) last traded at $28.08, with a market cap of 2.28B and a price-to-earnings ratio of 13.06.

Today the stock has traded between $27.30 and $28.29. The current price is 2.9% above the day's low and 0.7% below its high.

Volume so far is 707.86K shares, in line with the average of 672.43K shares a day.

Over the past year Pediatrix Medical Group has ranged from $16.47 to $28.02, and now sits 101% of the way up that range.

Pediatrix Medical Group met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.63 per share against an estimate of $0.6093.

The average analyst price target is $26.86, 4.3% below the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 3 analyst ratings say Buy
  • Buy0.0%
  • Hold100.0%
  • Sell0.0%
Price target · 9 analystsAvg $26.86
Low
$21.21
Now
$28.08
High
$29.40

MD earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 23.0% on average.

  1. Q3 FY24: reported $0.44 per share against an estimate of $0.3796
  2. Q4 FY24: reported $0.51 per share against an estimate of $0.3779
  3. Q1 FY25: reported $0.33 per share against an estimate of $0.2486
  4. Q2 FY25: reported $0.53 per share against an estimate of $0.4375
  5. Q3 FY25: reported $0.67 per share against an estimate of $0.4797
  6. Q4 FY25: reported $0.50 per share against an estimate of $0.5552
  7. Q1 FY26: reported $0.44 per share against an estimate of $0.3898
  8. Q2 FY26: reported $0.63 per share against an estimate of $0.6093

MD news

  • Press releaseBusiness Wire

    Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseBusiness Wire

    Pediatrix Medical Group Reports Second Quarter Results

  • Press releaseBusiness Wire

    Pediatrix Medical Group Provides Second Quarter Update

  • Tim Melvin

    Under the Radar: 5 Small-Cap Stocks Wall Street Is Missing

  • Press releaseBusiness Wire

    Pediatrix Medical Group Announces Publication of New Research Addressing Urgent Questions in Neonatology

  • Press releaseBusiness Wire

    Pediatrix Medical Group Reports First Quarter Results

  • Press releaseBusiness Wire

    Pediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026

Similar companies

Companies in the same industry as Pediatrix Medical Group

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.